ALLIANCE PHARMA PLC

Major Shareholding Notification • Apr 5, 2017

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 6866B

Alliance Pharma PLC

05 April 2017

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:			Alliance Pharma plc
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights				√
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached				√
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) subject to the notification obligation:		Aviva plc & its subsidiaries
4. Full name of shareholder(s)  (if different from 3.):		Registered Holder: Available on request                                        18,450* Chase (GA Group) Nominees Limited       35,223,402* *denotes direct interest Chase Nominees Limited                              1,165,093
5. Date of the transaction and date on which the threshold is crossed or reached:		3 April 2017
6. Date on which issuer notified:		5 April 2017
7. Threshold(s) that is/are crossed or reached:		8% to 7% Change at Direct Interest Level (Box 8A)

8. Notified details:
A: Voting rights attached to shares
Class/type of shares if possible using the ISIN CODE	Situation previous to the triggering transaction				Resulting situation after the triggering transaction
Number of Shares		Number of Voting Rights		Number of shares	Number of voting rights			% of  voting rights
Direct	Direct		Indirect	Direct		Indirect
Ordinary Shares GB0031030819	43,574,295*		43,574,295*		36,406,945	35,241,852		1,165,093	7.46%		0.24%
* Includes Right to Recall Loaned Shares (108,293)
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument		Expiration date		Exercise/ Conversion Period			Number of voting rights that may be acquired if the instrument is exercised/ converted.			% of voting rights
RIGHT TO RECALL LOANED SHARES		N/A		N/A			50,000* *Direct Interest			0.01%

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument	Exercise price	Expiration date	Exercise/ Conversion period	Number of voting rights instrument refers to	% of voting rights
					Nominal	Delta

Total (A+B+C)
Number of voting rights	Percentage of voting rights
36,456,945	7.71%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:
The voting rights are managed and controlled by Aviva Investors Global Services Limited and Friends Provident International Limited, with the following chain of controlled undertakings:- Aviva Investors Global Services Limited: ·      Aviva plc (Parent Company) ·      Aviva Group Holdings Limited (wholly owned subsidiary of Aviva plc) ·      Aviva Investors Holdings Limited (wholly owned subsidiary of Aviva Group Holdings Limited) ·      Aviva Investors Global Services Limited (wholly owned subsidiary of Aviva Investors Holdings Limited) Friends Provident International Limited: ·      Aviva plc (Parent Company) ·      Aviva Group Holdings Limited (wholly owned subsidiary of Aviva plc) ·      Friends Provident International Limited (wholly owned subsidiary of Aviva Group Holdings Limited)
Proxy Voting:
10. Name of the proxy holder:		See Section 4
11. Number of voting rights proxy holder will cease to hold:
12. Date on which proxy holder will cease to hold voting rights:
13. Additional information:	Figures are based on a total number of voting rights of  472,716,142, as per the Company's 'Application for admission' announcement of 14th February 2017.
14. Contact name:	James Clark, Aviva plc
15. Contact telephone number:	01603 683853

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLEAALSEAFXEFF